Insulin Glargine (U-300) Pens and Ustekinumab Subcutaneous Injection
Determining the interaction of Insulin Glargine (U-300) Pens and Ustekinumab Subcutaneous Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-300) Pens-Ustell
- Insulin Glargine (U-300) Pens-UTA
- Insulin Glargine (U-300) Pens-UTA Capsules
- Insulin Glargine (U-300) Pens-UTAC tablets
- Insulin Glargine (U-300) Pens-UTI Relief
- Insulin Glargine (U-300) Pens-Utibron Neohaler
- Ustekinumab Subcutaneous Injection-Insulin glargine and lixisenatide
- Ustekinumab Subcutaneous Injection-Insulin glargine and lixisenatide Subcutaneous
- Ustekinumab Subcutaneous Injection-Insulin glargine, recombinant Subcutaneous
- Ustekinumab Subcutaneous Injection-Insulin glulisine
- Ustekinumab Subcutaneous Injection-Insulin Glulisine (Cartridges and Pens)
- Ustekinumab Subcutaneous Injection-Insulin Glulisine (Vials)